Zai Lab nabs speedy Chi­na reg­u­la­to­ry re­view for PARP drug Ze­ju­la

Chi­nese reg­u­la­to­ry of­fi­cials are sig­nal­ing that they’re ready to whisk Ze­ju­la through the reg­u­la­to­ry process.

Zai Lab $ZLAB said this morn­ing that the Cen­ter for …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER